Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy
- PMID: 37094880
- DOI: 10.1136/ard-2023-223880
Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy
Abstract
No single organ has received as much attention in systemic lupus erythematosus (SLE) as the kidneys. During the period 2019-2022, the Annals of the Rheumatic Diseases published several original papers, brief reports and letters that further elucidate the pathogenesis and advance the management of LN. A selection of representative original papers is highlighted in this review.
Keywords: Autoimmunity; Lupus Erythematosus, Systemic; Lupus Nephritis.
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.Int J Mol Sci. 2019 Dec 10;20(24):6231. doi: 10.3390/ijms20246231. Int J Mol Sci. 2019. PMID: 31835612 Free PMC article. Review.
-
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.Int J Mol Sci. 2021 Jan 27;22(3):1263. doi: 10.3390/ijms22031263. Int J Mol Sci. 2021. PMID: 33514066 Free PMC article. Review.
-
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.Lupus. 2020 Aug;29(9):1011-1020. doi: 10.1177/0961203320932219. Epub 2020 Jun 22. Lupus. 2020. PMID: 32571142 Free PMC article. Review.
-
Belimumab for systemic lupus erythematosus - Focus on lupus nephritis.Hum Vaccin Immunother. 2022 Nov 30;18(5):2072143. doi: 10.1080/21645515.2022.2072143. Epub 2022 May 19. Hum Vaccin Immunother. 2022. PMID: 35588699 Free PMC article. Review.
-
Belimumab for the treatment of pediatric patients with lupus nephritis.Expert Opin Biol Ther. 2023 Mar;23(3):243-251. doi: 10.1080/14712598.2023.2178297. Epub 2023 Feb 17. Expert Opin Biol Ther. 2023. PMID: 36750049 Clinical Trial.
Cited by
-
Proteomics uncovers ICAM2 (CD102) as a novel serum biomarker of proliferative lupus nephritis.Lupus Sci Med. 2025 Apr 23;12(1):e001446. doi: 10.1136/lupus-2024-001446. Lupus Sci Med. 2025. PMID: 40274316 Free PMC article.
-
[What is proven in the treatment of systemic lupus erythematosus?].Z Rheumatol. 2024 Aug;83(6):439-446. doi: 10.1007/s00393-024-01551-6. Z Rheumatol. 2024. PMID: 39037548 Review. German.
-
Lupus nephritis-related chronic kidney disease.Nat Rev Rheumatol. 2024 Nov;20(11):699-711. doi: 10.1038/s41584-024-01158-w. Epub 2024 Sep 24. Nat Rev Rheumatol. 2024. PMID: 39317803 Review.
-
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances.Signal Transduct Target Ther. 2025 Apr 4;10(1):106. doi: 10.1038/s41392-025-02142-w. Signal Transduct Target Ther. 2025. PMID: 40180907 Free PMC article. Review.
-
Kidney transplantation in Lupus Nephritis: a comprehensive review of challenges and strategies.BMC Surg. 2025 Mar 22;25(1):112. doi: 10.1186/s12893-025-02832-w. BMC Surg. 2025. PMID: 40121458 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical